Biotech & Longevity

Biology is becoming programmable. Explore startups using AI for drug discovery, engineering gene therapies, and unlocking the science of human longevity.

60
Startups
$112.0B
Total Funding
6
Sector Queries
Updated Hourly

Top Startups in Biotech & Longevity

Ipsen

Ipsen

Global biopharmaceutical company focused on oncology, rare diseases, and neuroscience.

Biotech
MedTech
HealthTech
N/A
Paris
Neuralink

Neuralink

Neuralink develops brain-computer interface implants that enable direct communication between the human brain and computers, targeting paralysis and neurological conditions.

Neurotechnology
Brain-Computer Interface
Medical Devices
$650M
St. Jude Children’s Research Hospital

St. Jude Children’s Research Hospital

A leading children's research hospital dedicated to treating and curing childhood catastrophic diseases.

Healthcare
Biotechnology
Non-profit
$63M
Memphis

Founders Fund

Venture capital firm investing in revolutionary technologies and ambitious founders tackling big problems.

Venture Capital
Technology
Artificial Intelligence
$19.9B
San Francisco
Amgen

Amgen

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Biotech
MedTech
HealthTech
$40M
Thousand Oaks

Supernus Pharmaceuticals

Biopharmaceutical company developing and commercializing CNS disease treatments.

Biotechnology
Pharmaceuticals
Healthcare
$18M
Rockville
Moderna

Moderna

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology
mRNA Technology
Vaccines
$4.4B
Cambridge

Galderma Group

A global pure-play dermatology company focused on injectable aesthetics, dermatological skincare, and therapeutic medicine.

Healthcare
Biotechnology
Pharmaceuticals
$63M
Zug
BioNTech

BioNTech

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Biotechnology
Drug Discovery
Oncology
$975M
Mainz

Blackstone Life Sciences

Accelerating the development of breakthrough new medicines and medical technologies.

Life Sciences
Biotechnology
Pharmaceuticals
$6.2B
New York
Index Ventures

Index Ventures

Global venture capital firm backing ambitious entrepreneurs from seed to IPO across technology and life sciences.

Venture Capital
Growth Capital
Enterprise Software
$9.1B
London
Healthpeak Properties

Healthpeak Properties

A leading owner, operator, and developer of real estate for healthcare discovery and delivery.

Healthcare
Real Estate
Life Sciences
$20.0B
Denver
BeiGene

BeiGene

A global oncology company developing and commercializing innovative cancer treatments.

Biotech
MedTech
HealthTech
$358M
Cambridge
Allergan

Allergan

A global pharmaceutical company focused on developing and marketing innovative treatments.

Biotech
MedTech
HealthTech
$30.1B
Dublin
Kilo

Kilo

A high-velocity venture studio co-founding and investing in startups across health, longevity, beauty, and travel.

Health
Longevity
Beauty
$10M
Vilnius
Isomorphic Labs

Isomorphic Labs

AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.

Drug Discovery
Biotechnology
AI-Driven Drug Discovery
$2.6B
London

Kite Pharma

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Biotechnology
Pharmaceuticals
Oncology
$421M
Santa Monica
Immunai

Immunai

Healthcare
Immunology
Data
$295M
Ultima Genomics

Ultima Genomics

Life Sciences
Biotech
Bioinformatics
$600M
CytoReason

CytoReason

Healthcare
Drug Discovery
Clinical Development
$128M

CRISPR Therapeutics

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Biotechnology
Gene Editing
Therapeutics
$547M
Zug

Juno Therapeutics

Biotechnology company focused on developing cancer immunotherapies.

Biotechnology
Pharmaceuticals
Cancer Immunotherapy
$317M
Seattle
ŌURA

ŌURA

Wearable technology company developing smart rings for comprehensive sleep, activity, and health tracking.

Wearable Technology
HealthTech
Biotechnology
$875M
San Francisco
Cradle

Cradle

Cradle Bio B.V. is a Dutch–Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

Biotech
HealthTech
AI-Driven Protein Design
$102M
Amsterdam
PCI Pharma Services

PCI Pharma Services

A leading global contract development and manufacturing organization (CDMO) for innovative biologic and small molecule therapies.

Pharmaceuticals
Biotechnology
Contract Manufacturing
$63M
Philadelphia
Stryker Corporation

Stryker Corporation

A global leader in medical technology, developing innovative solutions for healthcare.

Medical Devices
Healthcare Technology
Biotechnology
N/A
Kalamazoo
Altos Labs

Altos Labs

Biotechnology company focused on cellular rejuvenation to reverse disease and extend healthspan.

Biotechnology
HealthTech
Longevity
$3.8B
Redwood City
Jacobs

Jacobs

Global technical professional services firm providing engineering, consulting, and technology solutions.

Engineering
Consulting
Infrastructure
N/A
Dallas
Dassault Systèmes

Dassault Systèmes

Global leader in 3D design, 3D digital mock-up, and product lifecycle management software solutions.

Software
Artificial Intelligence
3D Design
N/A
Vélizy-Villacoublay
IQVIA

IQVIA

Leveraging AI and advanced analytics to drive innovation in healthcare and life sciences.

Healthcare
Life Sciences
Data Analytics
N/A
Durham
Curia

Curia

Global contract research, development, and manufacturing organization for pharmaceutical and biopharmaceutical industries.

Contract Research Organization
Contract Development and Manufacturing Organization (CDMO)
Drug Discovery
$56M
Albany
Chai Discovery

Chai Discovery

AI-powered drug discovery platform using foundation models for molecular design.

Artificial Intelligence
Biotechnology
Drug Discovery
$2M
San Francisco
Calyxo

Calyxo

Redefining kidney stone treatment with an aspiration-based stone removal system.

Medical Devices
HealthTech
Biotechnology
$151M
Pleasanton

Causaly

AI-powered knowledge discovery for life sciences.

Biotechnology
Artificial Intelligence
Drug Discovery
$63M
London
Benchling

Benchling

R&D cloud for life sciences, with AI capabilities.

BIO + LIFE SCIENCES
Biotech
MedTech
$406M
Periodic Labs

Periodic Labs

AI-powered materials science and discovery platform to accelerate scientific breakthroughs.

Artificial Intelligence
Materials Science
Drug Discovery
$300M
San Francisco
Xaira Therapeutics

Xaira Therapeutics

AI-powered biotech platform using protein design to discover novel therapeutic molecules.

Artificial Intelligence
Biotechnology
Drug Discovery
$1.0B
San Francisco
Celerion

Celerion

A global leader in clinical pharmacology and bioanalytical sciences.

Biotechnology
Pharmaceuticals
Healthcare
$45M
Lincoln

Lakestar

European venture capital firm focused on early-stage technology companies.

Venture Capital
Technology
Deep Tech
$1.5B
Berlin
Azurity Pharmaceuticals

Azurity Pharmaceuticals

Azurity Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing high-quality, affordable liquid medications.

Pharmaceuticals
Healthcare
Biotechnology
$1.1B
Woburn
NNIT

NNIT

Global IT services and consulting company for life sciences and enterprise businesses.

IT Services
IT Consulting
Digital Transformation
$13M
Copenhagen

MacroGenics

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Biotech
MedTech
HealthTech
$14M
Rockville
Altasciences

Altasciences

Integrated drug development solutions for pharmaceutical and biotechnology companies, from preclinical to clinical trials.

Biotech & Longevity
Drug Discovery
Clinical Trials
$79M
Laval

Denali Therapeutics

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Biotech
HealthTech
Drug Discovery
$1.0B
South San Francisco

Varda Space Industries

Developing reusable spacecraft to manufacture pharmaceuticals and high-end materials in microgravity for Earth use.

Aerospace
Space Technology
Manufacturing
$328M
El Segundo

Lila Sciences

AI-driven lab automation for biological research and discovery at scale.

Artificial Intelligence
Biotechnology
Lab Automation
$200M
Cambridge

Science

Developing advanced vision restoration technology through a retinal implant.

Biotechnology
Medical Devices
Artificial Intelligence
$230M
San Francisco

Seaport Therapeutics

Developing novel therapeutics to restore gut lymphatic function.

Biotechnology
Pharmaceuticals
HealthTech
$340M
Cambridge
Owkin

Owkin

AI company using federated learning to solve biological complexity and accelerate drug discovery.

Artificial Intelligence
Biotechnology
Healthcare
$80M
New York

ConcertAI

Enterprise AI and real-world data SaaS solutions for life sciences and healthcare clinical research.

AI
SaaS
HealthTech
$300M
Cambridge
Recursion Pharmaceuticals

Recursion Pharmaceuticals

Uses AI and automation to industrialize drug discovery and development for rare diseases and cancers.

Drug Discovery AI
Biotech
MedTech
$623M
Salt Lake City
NewLimit

NewLimit

NewLimit is developing epigenetic therapies to extend human healthspan by reprogramming aging cells.

Biotech
Longevity
Epigenetics
$215M
San Francisco Bay Area
Atomwise

Atomwise

Drug Discovery
Life Sciences
Healthcare
$176M
Insitro

Insitro

Healthcare
Drug Discovery
Drug Development
$243M
C2i Genomics

C2i Genomics

Healthcare
Genomics
Cancer
$112M
AtaiBeckley

AtaiBeckley

A clinical-stage biopharmaceutical company developing psychedelic-based therapies for mental health disorders.

Biotech & Life Sciences
MedTech
HealthTech
$640M
New York
Janux Therapeutics

Janux Therapeutics

A clinical-stage biopharmaceutical company developing novel immunotherapies.

Biotechnology
Pharmaceuticals
Healthcare
$181M
San Diego
Upstream Bio

Upstream Bio

Life Sciences
Therapeutics
Biotech
$400M
Tropic

Tropic

Genetics
Crop
Agritech
$166M
Karius

Karius

Life Sciences
Biotech
Genomics
$315M
Biotech is being reinvented by software. AI-first drug discovery companies (Recursion, Insitro, Insilico Medicine) have raised $10B+ combined, and the first AI-discovered drugs are entering Phase II clinical trials. The promise: reducing the average $2.6B cost and 10-year timeline of bringing a drug to market by 50-70%. The longevity sector has gone from fringe to mainstream. Altos Labs ($3B from Jeff Bezos), Calico (Google), and Unity Biotechnology are pursuing cellular reprogramming, senolytic therapies, and epigenetic clocks. Bryan Johnson's Blueprint protocol has turned anti-aging into a consumer movement. The science is real: rapamycin, metformin, and NAD+ precursors show genuine promise in clinical settings. What makes modern biotech different from the last generation is the convergence of AI, CRISPR, and cloud biology. Startups can now screen millions of compounds computationally, edit genes with precision, and run experiments on robotic lab platforms (Strateos, Emerald Cloud Lab). This dramatically reduces the capital required to reach clinical-stage data, making biotech fundable for VCs who previously avoided the space. The TAM is healthcare itself — a $12T global market.

Explore More Startups

Search any AI startup in our database